
News|Articles|April 16, 2014
AMRI Closes Facility in NY
Author(s)Pharmaceutical Technology Editors
AMRI will close its DDS facility in Syracuse, NY.
Advertisement
AMRI
reported that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, NY site to other sites within AMRI and will terminate all operations in Syracuse by the end of June 2014.
As part of the transition, Syracuse DDS capabilities and some employees will be transferred to other AMRI facilities, including Albany, NY; Cedarburg, Wis.; Holywell, UK; and Hyderabad, India. AMRI expects the closure will generate annual run-rate savings of approximately $1.5 million.
Source:
AMRI
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
3
Technology Transfer: Success Drivers and Obstacles Explained
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5




